Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Richard Nicholas

Richard Nicholas is a freelance contributor for Animal Pharm, providing analysis of new patents. He looks at R&D trends through the patenting patterns of the industry’s leading innovators. He has worked in the animal health sector for 15 years.
Set Alert for Articles By Richard Nicholas

Latest From Richard Nicholas

Bayer, Elanco and Merial add to patent portfolios

In a busy month of new patent applications, three of the largest companies each fielded three innovative approaches to animal health.  

R&D Policy & Regulation

Vaccines and gene therapy head latest patent applications

New patent applications published in July focused mainly on new biologic approaches, including livestock vaccines and canine gene therapy.

R&D Pharmaceuticals

Big players continue to add to patent portfolios

Last month saw a bumper collection of new patent applications featuring innovations made by the leading animal health companies.

R&D Antiparasitics

Monthly patent applications feature teat seal innovations

Last month saw fewer new patent applications of note made by the leaders of the animal health industry. Of these, two focused on new teat seal technology for the prevention of mastitis.

Pharmaceuticals Antiparasitics

Crossover from human medicinal research provides new patent applications for Elanco

Last month saw the publication of new patent applications reflecting innovation across the field of veterinary medicine research, and included applications from Eli Lilly (Elanco) with roots in research for human medicine.

Antiparasitics Vaccines

Boehringer dominates new patent applications

The past month has seen fewer new patent applications by the leading animal health companies, with Boehringer Ingelheim Vetmedica and its merger partner Merial dominating the list.

Vaccines Boehringer Ingelheim Animal Health
See All